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Many effective drugs, biologics and devices exist.
Because of this, it is often considered unethical to
undertake placebo controlled clinical trials to evaluate
new treatments. Rather, randomized active control non-
inferiority trials have become the norm. These trials,
however, are accompanied by serious issues including
selecting an active comparator, identifying previously
run active comparator placebo controlled trials, deciding
upon the form of comparison (e.g., differences or ratios),
setting a non-inferiority margin, designing a new study
where consistency with past trials hold, finding study
sites where the trial can be performed, selecting the
appropriate analysis set (Intent-to-treat or per protocol)
and determining sample size. These issues have proven
to be more problematic than naively anticipated. Further
with the accumulation and advancement of these studies
and the attempt to expand their use, new problems
arose and others can be anticipated to arise. Some com-
mon problems are the realization that consistency with
previous active comparator placebo trials does not hold,
that the multiple available ad hoc (non-theory driven)
tests present confusion rather than help and that the
outcome data for the active comparator often do not
match the anticipated results. Newer problems are the
attempts of switching from non-inferiority to superiority
testing and superiority to non-inferiority testing, the use
of interim analyses, multiple treatments and dealing
with recurrent events as the trial outcomes. In this talk
we present a brief overview of the above beginning with
the migration from equivalency test to non-inferiority
test, moving through the issues and with emphasis on
the major problems.
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